Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
5,225
datasets available to search
ShareScore release 0.9.0
Dataset results
5,225 results for “moderation”
A Clinical Trial of Natalizumab in Individuals With Moderately to Severely Active Crohn's Disease
ClinicalTrials.gov study NCT00078611. IPD Sharing: Not stated. Countries: 2. Publications: 0.
A Clinical Trial to Compare Topical Agents in Adults With Mild to Moderate Atopic Dermatitis (AD)
ClinicalTrials.gov study NCT02376049. IPD Sharing: NO. Countries: 2. Publications: 0.
Nipocalimab in Moderate to Severe Sjogren's Disease
ClinicalTrials.gov study NCT06741969. IPD Sharing: YES. Countries: 25. Publications: 0.
Efficacy and Safety of Tian Ma Bian Chun Zhi Gan Tablets in Mild to Moderate Vascular Dementia
ClinicalTrials.gov study NCT05371639. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase 2b Study of EVO756 in Adults With Moderate to Severe Chronic Spontaneous Urticaria (CSU)
ClinicalTrials.gov study NCT06873516. IPD Sharing: NO. Countries: 3. Publications: 0.
Crossbow Versus Forsus Springs in Mild to Moderate Class II Malocclusion Cases
ClinicalTrials.gov study NCT01530516. IPD Sharing: NO. Countries: 1. Publications: 0.
Phase 1 Study of CC-90005 in Healthy Subjects and Subjects With Moderate to Severe Plaque-type Psoriasis
ClinicalTrials.gov study NCT02502188. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study in Patients With Moderated to Severe Rheumatoid Arthritis Who Have Failed to Combination Therapy of Conventional Disease-modifying Antirheumatic Drugs (cDMARDs) to cDMARD Plus ANti-TNF Versus cD
ClinicalTrials.gov study NCT03264703. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Evaluate IBI112 in the Treatment of Subjects With Moderate to Severe Plaque Psoriasis
ClinicalTrials.gov study NCT05003531. IPD Sharing: NO. Countries: 1. Publications: 0.
Evaluation of 611 in Chinese Adults With Moderate to Severe Chronic Obstructive Pulmonary Disease
ClinicalTrials.gov study NCT06099652. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of LIV001 in Healthy Subjects and Those with Mild-to-Moderate Active Ulcerative Colitis (UC)
ClinicalTrials.gov study NCT05975047. IPD Sharing: NO. Countries: 1. Publications: 0.
Evaluation of 611 in Combination With Topical Corticosteroid in Participants With Moderate to Severe Atopic Dermatitis
ClinicalTrials.gov study NCT06554847. IPD Sharing: NO. Countries: 1. Publications: 0.
Pharmacokinetics of Peginterferon Alfa-2b in Participants With Moderate and Severe Renal Impairment (P05655)
ClinicalTrials.gov study NCT01432535. IPD Sharing: YES. Countries: 0. Publications: 0.
A Safety and Efficacy Evaluation of Topical Treatments for Moderate-Severe Facial Acne Vulgaris
ClinicalTrials.gov study NCT02604680. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study in Subjects With Moderate Atopic Dermatitis
ClinicalTrials.gov study NCT03859986. IPD Sharing: UNDECIDED. Countries: 2. Publications: 0.
To Evaluate the Safety, Tolerability, Pulmonary Deposition, Pharmacokinetics and Pharmacodynamics of Ciprofloxacin Inhale in Japanese Patients With Moderate to Severe Chronic Obstructive Pulmonary Dis
ClinicalTrials.gov study NCT01072942. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Potential of Moderate Whole Body Hyperthermia to Enhance Response
ClinicalTrials.gov study NCT05821166. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
ClinicalTrials.gov study NCT07082738. IPD Sharing: YES. Countries: 24. Publications: 0.
Safety, Tolerability, Pharmacokinetics and Efficacy of Twice Daily Application of Topical BioLexa in Adult Healthy Subjects and Patients With Mild to Moderate Atopic Dermatitis
ClinicalTrials.gov study NCT04544943. IPD Sharing: NO. Countries: 1. Publications: 0.
Retrospective Chart Review to Evaluate Safety and Tolerability of ADVATE Among Previously Untreated Patients in China With Moderate to Severe Hemophilia A
ClinicalTrials.gov study NCT02634723. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.